Next generation
near-patient diagnostics

Sexually transmitted infection management

Next generation near-patient diagnostics

Sexually transmitted infection management

Next generation near-patient diagnostics

Sexually transmitted infection management

Over 1 million new cases of sexually transmitted infections diagnosed every day, with an estimated market size of over $30 billion.

Sources: WHO, 2019 and Fior Markets, 2019

Our innovative technology using EXPAR and Linear Dichroism provides the results in under 15 minutes

Our innovative technology using EXPAR and Linear Dichroism provides the results in under 15 minutes

Designed for rapid Point-of Care testing for sexually transmitted infections and other infectious diseases

Company

Delivering enhanced diagnostic solutions through novel technology

Technology

Our patented linear dichroism technology has a number of distinct advantages in that, not only does it provide very accurate results, but can measure multiple targets simultaneously

Solutions

Initially focused on sexually transmitted infections the technology can be utilised in a wide range of diagnostic applications

Delivering rapid results at the STI clinic

  • Immediate treatment of positive patients
  • Decrease onward transmission
  • Lower the risk of antibiotic resistance
  • Reduce healthcare costs
  • Improve the patient experience